WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.140
- -0.050-4.20%
Close Feb 25 16:00 ET
- 1.290
- +0.150+13.16%
Pre 07:00 ET
15.62MMarket Cap-5.43P/E (TTM)
1.250High1.140Low133.96KVolume1.160Open1.190Pre Close160.20KTurnover8.64%Turnover RatioLossP/E (Static)13.70MShares4.00052wk High4.69P/B1.77MFloat Cap0.85152wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM9.24%Amplitude0.851Historical Low1.195Avg Price1Lot Size
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025
Kairos Pharma Stock Forum
Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma
February 26, 2025 07:00 AM Eastern Standard Time
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced that the company presented preclinical data on its investigational compounds KROS 101 and KROS 401 during the...
Major Clinical Trial Update: KAPA's Prostate Cancer Drug Gets Prestigious Cancer Center Backing
Groundbreaking Cancer Drug KROS101 Outperforms Existing Treatment in Melanoma Studies
Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound's Potential as a Therapeutic for Melanoma and Glioblastoma
Thursday, 6th February at 8:30 am
Kairos Pharma, Ltd. (NYSE: KAPA), a clinical-stage biopharmaceutical company, announces that the Company presented a talk during the plenary session of the joint AACR-JCA conference, From Cancer Discovery Science to Therapeutic Innovation, highl...
beautiful pump in
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
No comment yet